Clinical Trial Update: Oral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm Infants [NA]

View source ↗

Summary

A clinical trial update reports that oral propranolol may improve outcomes in retinopathy of prematurity among very preterm infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Huiqing Sun | Conditions: Retinopathy of Prematurity | NA | Status: UNKNOWN